CPHI Milan 2026
10/2026 – 10/2026
회사 소개
- 법인명: ANFARM HELLAS S.A.
- 등록 국가: Greece
- 주소: Perikleous 53-57 Gerakas, 15344 Athens, Greece
설명:
A leading EU GMP pharmaceutical manufacturer established in 1967, engaged in the development, production, licensing and global sale of quality generic pharmaceuticals. Main activities include licensing-out and international sales, technology transfer and contract manufacturing, contract development, new product development, lyophilization cycle development and optimization, and regulatory affairs services.
사업 활동
완제 의약품
제조업체위탁제조업체 (CMO)규제 컨설턴트
계약 및 아웃소싱 서비스
서비스 제공업체위탁제조업체 (CMO)규제 컨설턴트
포장재
위탁제조업체 (CMO)규제 컨설턴트
판매 시장
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syria, Turkey, Yemen
- Northern Europe: Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom
- Southern Europe: Albania
주요 제품/서비스
- 원료의약품(API): Meropenem Pd.I.S.Inf 500mg/Vial, 1g/Vial & 2g/Vial (EU CTD Available), Moxifloxacin Sol.Inf 400mg/250ml (250ml Bottle) (EU CTD Available)
- 계약 및 아웃소싱 서비스: Esomeprazole Pd.I.S.Inf 40mg/Vial (EU CTD Available), Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available), Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available), Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available), Daptomycin Pd.I.S.Inf. 350 & 500mg/Vial (EU CTD Available), Isavuconazole Pd.C.So.In 200mg/Vial (under development), Tigecycline Pd.Sol.Inf 50mg/Vial (EU CTD Available), Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available), Omeprazole Pd.Sol.Inf 40mg/vial (EU CTD Available), Omeprazole Ps.Inj.Sol 40mg/vial (EU CTD Available), Pantoprazole Pd.Inj.Sol 40mg/Vial (EU CTD Available), Tenoxicam Ps.Inj.Sol 20mg/Vial (EU CTD Available), Vancomycin Pd.Sol.Inf 500mg/Vial (EU CTD Available) & 1g/vial (EU CT Available: Q3 2021)
- 완제 의약품: Omeprazole Gr.Cap 20mg & 40mg (EU CTD Available), Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021), Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development), Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022), Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022), Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available), Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development), Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available), Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available), Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022), Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available), Ertapenem Pd.C.So.In 1g/Vial (under development), Imipenem + Cilastatin Pd.Sol.Inf (500+500)mg/Vial (EU CTD Available), Lacosamide Oral Solution 10mg/ml (EU CTD Available: Q2 2022), Lacosamide Solution for Infusion 10mg/ml (EU CTD Available: Q2 2021), Levofloxacin Sol.Inf 5mg/ml (100ml Bottle) (EU CTD Available), Linezolid Inj.Sol. 2mg/ml (300ml Plastic Bag) (EU CTD Available), L-Carnitine Oral Solution 1g/10ml Vial (EU CTD Available)
- ATC 분류체계 (해부치료화학분류): Palonosetron Inj.Sol. 250mcg/5ml (Vial) (EU CTD Available), Vildagliptin & Metformin Tabs (50+850 mg), (50+1000 mg) (EU CTD Available: Q3 2021), Fosfomycin Pd.Sol.Inf 40mg/m, Aripiprazole Oral Solution 1mg/ml, Somatostatin Ps.Sol.Inf. 3mg/Vial (EU CTD Available)
- 오리지널 원료의약품: Ceftazidime/ Avibactam Pd.C.S.Inf (2+0.5)g/vial
당사 제품 & 서비스
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
증거
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기